
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES133
One RCT257 reported that the incidence of hyperkalaemia (necessitating discontinuation of the study medication) was significantly higher in patients receiving irbesartan as compared to those receiving amlodipine. Level 1++

[@Holzgreve_2003]

